1 Product identity
Ingredient risk
1 ingredient to use with caution
Caprystatin
BrandEcological Formulas→Other Combinations Capsule 7 ingredients 1 caution DSLD #22286Net contents: 90 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-06-25
2 Ingredients (7)
IngredientGroupSafety
Caprylic AcidCaprylic Acid—
Microcrystalline CelluloseCellulose—
Hydroxypropyl MethylcelluloseHypromellose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• Structure/Function
5 Data source
DSLD ID22286
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-06-25
6 More from Ecological Formulas
View Ecological Formulas Safety Scorecard → 74 products
Allithiamine 50 mgAnti-Mutagens With Ellagic AcidB Cell FormulaB12 Folic Acid Spray LipopureBlack Elderberry ExtractBuffered Vitamin C Crystals7 Cite this page
Vancouver
Pkhakadze G. Caprystatin — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/dsld-22286/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG